Lim Jonathan E

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$4.73M
Insider Sells Quantity
8
Insider Sells Sum
$3.5M

Insider Activity of Lim Jonathan E

According to the SEC Form 4 filings, Lim Jonathan E, being in a position of

  1. Chairman & CEO at Erasca, Inc.,
    оver the last 12 months, has bought 1000000 shares for $1.7M, and sold 0 shares,
    over all time since 2022-12-14, has bought 2300000 shares for $4.71M, and sold 0 shares.

The largest purchase of all time was on 2023-10-05 and amounted to 1000000 shares of Erasca, Inc. for $2.03M.

The largest sale of all time was on 2008-03-20 and amounted to 250000 shares of Halozyme Therapeutics, Inc. for $1.51M.

Biography of Lim Jonathan E

No biography is available at this moment.

2023-12-06PurchaseErasca, Inc.
ERAS
Chairman & CEO
278,150
0.1825%
$1.72$478,418+23.99%
2023-12-05PurchaseErasca, Inc.
ERAS
Chairman & CEO
721,850
0.4606%
$1.69$1.22M+24.93%
2023-10-05PurchaseErasca, Inc.
ERAS
Chairman & CEO
1M
0.695%
$2.03$2.03M+2.83%
2023-06-08PurchaseErasca, Inc.
ERAS
Chairman & CEO
100,000
0.0676%
$2.75$275,000-18.38%
2023-03-28PurchaseErasca, Inc.
ERAS
Chairman & CEO
100,000
0.0693%
$2.84$284,000-12.41%
2023-01-10PurchaseErasca, Inc.
ERAS
Chairman & CEO
60,000
0.0413%
$3.86$231,420-29.33%
2022-12-14PurchaseErasca, Inc.
ERAS
Chairman & CEO
40,000
0.0338%
$4.99$199,600-43.44%
2008-03-20SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
250,000
0.2968%
$6.06$1.51M-13.65%
2007-11-30SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
20,000
0.0261%
$8.24$164,796-30.9%
2007-10-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
25,000
0.0331%
$9.03$225,850-31.48%
2007-09-28SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
25,000
0.033%
$8.78$219,524-24.17%
2007-08-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
25,000
0.0322%
$8.69$217,347-25.2%
2007-07-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
20,000
0.0267%
$8.20$163,933-17.66%
2007-06-29SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
50,000
0.0701%
$9.49$474,456-27.84%
2007-05-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
50,000
0.0697%
$10.42$521,007-26.05%
2004-08-18PurchaseHalozyme Therapeutics, Inc.
HALO
President and CEO
10,000
0.0253%
$1.61$16,100+18.01%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.